West Virginia 2025 Regular Session

West Virginia House Bill HB2621

Introduced
2/19/25  

Caption

Relating to petition for involuntary treatment for drug and alcohol abuse

Impact

The implications of HB2621 are significant as it amends existing codes to introduce a structured legal pathway for involuntary treatment. This will embed the criteria for such treatment in state law, thus potentially increasing the number of individuals who receive court-mandated help. The bill specifies that involuntary treatment can only be ordered if certain conditions are met, including presenting an imminent threat of danger and the potential for benefit from treatment. This may serve to streamline the process for caregivers and family members seeking assistance for their loved ones.

Summary

House Bill 2621 focuses on the process of involuntary treatment for individuals suffering from substance use disorders in West Virginia. The bill aims to establish clear procedures and criteria for initiating involuntary treatment through court petitions. It outlines the rights of individuals undergoing treatment, ensuring that they are afforded rights similar to those of involuntarily hospitalized mentally ill persons. This framework is designed to facilitate necessary treatment for those who present a danger to themselves or others due to substance abuse issues.

Sentiment

The general sentiment around HB2621 appears to be cautious yet optimistic. Supporters believe that formalizing involuntary treatment procedures is crucial in addressing the ongoing substance use crisis. There is hope that this bill will facilitate timely intervention for individuals who are unable to seek help voluntarily due to their condition. However, there are concerns regarding the potential for misuse of the involuntary treatment provisions and the ethical implications of forcing treatment on individuals who may not consent.

Contention

Notable points of contention surrounding the bill revolve around the balance of individual rights versus societal safety. Critics argue that involuntary treatment could violate personal liberties and lead to negative experiences for those subjected to it without proper safeguards. There are discussions about ensuring adequate oversight processes to prevent abuse of power in the enforcement of this bill. The potential for stigma attached to those who undergo involuntary treatment is also a topic of concern, highlighting the need for sensitive implementation of the bill's provisions.

Companion Bills

No companion bills found.

Previously Filed As

WV SB1013

Prohibiting payment to residential substance use disorder treatment facilities in certain circumstances

WV HB113

Prohibiting payment to residential substance use disorder treatment facilities that do not meet certain requirements

WV HB116

Relating to authorizing the Public Employee Insurance Agency to provide insurance coverage for certain prescribed weight loss medications

WV HB115

Relating to the amount of surplus deposited into the Revenue Shortfall Reserve Fund and providing for an effective date

WV HB114

Relating to political party nomination of presidential electors

WV SB1014

Clarifying procedure for political party nomination of presidential electors

WV SB1001

Supplementing and amending appropriations to Department of Health and Department of Human Services

WV HB101

Supplementing and amending appropriations to the Department of Health and Department of Human Services

WV SCR102

Extending State of Emergency and suspending certain requirements for Free Application for Federal Student Aid

WV SB1006

Making supplementary appropriation to Bureau for Medical Services, Policy and Programming, and to BOE

Similar Bills

WI AB925

Revising various provisions of the statutes for the purpose of making corrections and reconciling conflicts (Correction Bill).

WI SB904

Revising various provisions of the statutes for the purpose of making corrections and reconciling conflicts (Correction Bill).

US HB238

Residential Substance Use Disorder Treatment Act of 2023 This bill revises and reauthorizes through FY2027 grants for residential substance use disorder treatment programs at state and local correctional and detention facilities. Among the revisions, the bill replaces statutory references to substance abuse with substance use disorder, specifies that the term residential substance use disorder treatment program includes a medication-assisted treatment program, requires the chief medical officer or other staff overseeing a program to complete training on the science of addiction and the latest research and clinical guidance on treating substance use disorders in criminal justice settings, and allows people who are awaiting trial or in pretrial detention to participate in the programs.

NM HB152

Medically Assisted Treatment For Juveniles

NH HB751

Requiring licensure of outpatient substance use disorder treatment facilities and relative to complaint investigation of treatment facilities by the department of health and human services office of the ombudsman and making an appropriation therefor.

PA SB691

Establishing the Nonnarcotic Medication Substance Use Disorder Treatment Program; in organization and jurisdiction of courts of common pleas, providing for court assessments for substance use disorder treatment; in other criminal provisions, further providing for supervisory relationship to offenders; and, in Pennsylvania Board of Probation and Parole, further providing for supervisory relationship to offenders.

MA H2227

Replacing archaic and stigmatizing language for substance use

MO SB218

Modifies provisions relating to court operations